Integrated Dermatology Partners with Dermatology Center of Loudoun, Expanding Presence in Northern Virginia
BOCA RATON, Fla.--(BUSINESS WIRE)-- Integrated Dermatology, the country's largest independent dermatology provider, has partnered with Dermatology Center of Loudoun, serving the Northern Virginia community since 2007. Founded by Jane T. Nguyen, MD, and Khoa Tran, MD, the practice opened its first location in Lansdowne, VA, and has since expanded to Aldie, VA.
'Drs. Nguyen and Tran have built a practice rooted in clinical excellence and strong patient trust, making Dermatology Center of Loudoun a natural fit for Integrated Dermatology,' said Integrated Dermatology Co-Founder and Executive Chairman Jeff Queen.
Dermatology Center of Loudoun offers a full range of medical, surgical, and cosmetic dermatology services. The experienced team includes Drs. Nguyen and Tran, along with Sofia Hanger, PA-C, Keri Church, PA-C, and Meredith Mahen, PA-C. Serving patients of all ages, the practice provides expert care in early skin cancer detection and advanced surgical treatments to support long-term skin health.
'Drs. Nguyen and Tran have built a practice rooted in clinical excellence and strong patient trust, making Dermatology Center of Loudoun a natural fit for Integrated Dermatology,' said Integrated Dermatology Co-Founder and Executive Chairman Jeff Queen. 'Their focus on autonomy and exceptional treatment aligns with our goal to empower dermatologists while expanding access to outstanding care.'
Integrated Dermatology, a family-owned company established in 2004, operates practices in 28 states across the U.S. The company offers dermatologists a unique partnership model that includes profit-sharing, control over operational and medical decisions and a significant wealth creation opportunity.
'Our priority has always been delivering high-quality care to every patient,' said Dr. Nguyen. 'This partnership supports our long-term vision for the practice, helping us reach more patients, invest in new resources, and continue delivering the dermatologic care our community relies on.'
A native of the Washington, D.C. area, Dr. Nguyen graduated summa cum laude from the University of Virginia as an Echols Scholar before earning her medical degree from the University of Pennsylvania, where she was inducted into the Alpha Omega Alpha Medical Honor Society. She is board-certified in dermatology with special interests in skin cancer and pediatric dermatology.
Dr. Tran earned his medical degree from New York Medical College and completed his internal medicine residency at the Hospital of the University of Pennsylvania. He later served as a clinical instructor at Thomas Jefferson Medical College in Philadelphia before relocating to Northern Virginia. Board-certified in internal medicine, he has specialized training in laser medicine and focuses on cosmetic and medical laser therapies.
For more information about Integrated Dermatology, visit https://mydermgroup.com. To learn more about Dermatology Center of Loudoun, visit https://dermloudoun.com.
Headquartered in Boca Raton, Florida, Integrated Dermatology is one of the largest providers of dermatology services, empowering doctors nationwide through practice acquisitions, physician partnerships and new practice formations. Founded in 2004, the company operates in 28 states and enables its dermatologists to maintain their medical autonomy. With a doctor-driven philosophy and focus on high-quality patient care, Integrated Dermatology provides unparalleled back-office support, including accounting, payroll, human resources and much more. The company also offers career opportunities for dermatologists seeking to join an established practice. For additional information, visit mydermgroup.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 hours ago
- Yahoo
Walton County Overdose Prevention Task Force celebrates Revive Awareness Day
WALTON COUNTY, Fla. (WMBB) – In 2024, Governor DeSantis signed a bill that designates June 6 as a day to bring attention to drug overdoses and the tools used to save lives. Local officials, health professionals and overdose survivors gathered at the North Walton Doctors Hospital to celebrate their first Revive Awareness Day. 'There is nothing more heartbreaking than seeing a young person die from a drug overdose because that is 100% preventable,' North Walton Doctors Hospital Chief Executive Dr. Guy Nguyen said. Dr. Nguyen said he has spent most of his career amid the opioid epidemic. He's seen firsthand how naloxone, an opioid antagonist that can reverse overdoses from substances like fentanyl, can save users from certain death. 'Sometimes they jump out of the bed and they want to hit you because you just took away their high,' Dr. Nguyen continued. It worked for Samara Bailey, whose overdose began her long road to recovery. 'The only thing I remember is waking up in an emergency room similar to this, and the nurse telling me, 'honey, you just died,'' overdose survivor Samara Bailey said. Because of her drug use, Bailey found herself in the Okaloosa County Jail, a circumstance law enforcement officials are all too familiar with. 'A lot of people come to jail and they are addicted, and that could very well be one of the reasons that they are in jail to begin with, and a lot of cases it is,' said WCSO Chief of Emergency Services Tracey Vause. But through hard work, dedication and community support, Bailey completed her road to recovery. Bailey, like many other former addicts, are making the best out of their second chance. 'I'm very, very blessed to be able to say that I get to show up as a loving husband, a father and a grandfather now, which I'm very happy about,' overdose survivor Chris Hockman said. To contact the Walton County Overdose Prevention Task Force, call (850) 401-6338. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
9 hours ago
- Yahoo
Cameco Reports Expected Increase in Its Share of Westinghouse 2025 Adjusted EBITDA
All amounts in Canadian dollars unless specified otherwise SASKATOON, Saskatchewan, June 06, 2025--(BUSINESS WIRE)--Cameco (TSX: CCO; NYSE: CCJ) reports an expected increase of approximately $170 million (US) in our 49% equity share of Westinghouse Electric Company's (Westinghouse) 2025 second quarter and annual adjusted EBITDA. The expected increase is tied to Westinghouse's participation in the construction project for two nuclear reactors at the Dukovany power plant in the Czech Republic. This expected increase will be taken into consideration in determining the 2025 distribution payable by Westinghouse to Cameco. In addition to the increase in adjusted EBITDA in 2025, we expect significant financial benefits for Westinghouse, as a subcontractor, over the term of the Dukovany construction project and related to the provision of the fuel fabrication services required for both reactors for a specified period. The outlook for Westinghouse's compound annual growth rate for adjusted EBITDA remains 6% to 10% over the next five years, excluding the impact of the expected $170 million (US) increase in its 2025 adjusted EBITDA. Cameco owns a 49% interest in Westinghouse and its partner, Brookfield Renewable Partners, owns the remaining 51%. Caution about forward-looking informationThis news release includes statements and information about our expectations for the future, which we refer to as forward-looking information. Forward-looking information is based on our current views, which can change significantly, and actual results and events may be significantly different from what we currently expect. Examples of forward-looking information in this news release include our expectations regarding: Westinghouse's participation in the Dukovany power plant construction project; an increase in Westinghouse's adjusted EBITDA; Westinghouse taking this increase into consideration in determining the 2025 distribution payable to Cameco; the financial benefits for Westinghouse, as subcontractor, over the term of the Dukovany construction project and the expected future growth in Westinghouse's compound annual growth rate for adjusted EBITDA. Material risks that could lead to different results include the risk that Westinghouse is not able to participate in the Dukovany construction project on a basis that achieves the currently expected benefits to Westinghouse for any reason, or that Cameco may not derive the expected increases in its share of Westinghouse's adjusted EBITDA, or that Westinghouse does not achieve the expected future annual growth in adjusted EBITDA. In presenting the forward-looking information, we have made material assumptions which may prove incorrect about Westinghouse's participation in the Dukovany construction project and related potential benefits to Westinghouse, and continuing growth in Westinghouse's compound annual growth rate for adjusted EBITDA. Non-IFRS MeasuresAdjusted EBITDA is a measure that does not have a standardized meaning or a consistent basis of calculation under International Financial Reporting Standards (a non-IFRS measure). Westinghouse's adjusted EBITDA is defined as its net income, adjusted for the impact of certain expenses, costs, charges or benefits incurred in such period which are either not indicative of underlying business performance or that impact the ability to assess the operating performance of its business. For more information regarding our use of this non-IFRS measure see our most recent annual and quarterly Management's Discussion and Analysis. ProfileCameco is one of the largest global providers of the uranium fuel needed to power a secure energy future. Our competitive position is based on our controlling ownership of the world's largest high-grade reserves and low-cost operations, as well as significant investments across the nuclear fuel cycle, including ownership interests in Westinghouse Electric Company and Global Laser Enrichment. Utilities around the world rely on Cameco to provide global nuclear fuel solutions for the generation of safe, reliable, carbon-free nuclear power. Our shares trade on the Toronto and New York stock exchanges. Our head office is in Saskatoon, Saskatchewan, Canada. As used in this news release, the terms we, us, our, the Company and Cameco mean Cameco Corporation and its subsidiaries unless otherwise indicated. View source version on Contacts Investor inquiries Cory Kos 306-716-6782 cory_kos@ Media inquiries Veronica Baker 306-385-5541 veronica_baker@ Sign in to access your portfolio
Yahoo
9 hours ago
- Yahoo
Cameco Reports Expected Increase in Its Share of Westinghouse 2025 Adjusted EBITDA
All amounts in Canadian dollars unless specified otherwise SASKATOON, Saskatchewan, June 06, 2025--(BUSINESS WIRE)--Cameco (TSX: CCO; NYSE: CCJ) reports an expected increase of approximately $170 million (US) in our 49% equity share of Westinghouse Electric Company's (Westinghouse) 2025 second quarter and annual adjusted EBITDA. The expected increase is tied to Westinghouse's participation in the construction project for two nuclear reactors at the Dukovany power plant in the Czech Republic. This expected increase will be taken into consideration in determining the 2025 distribution payable by Westinghouse to Cameco. In addition to the increase in adjusted EBITDA in 2025, we expect significant financial benefits for Westinghouse, as a subcontractor, over the term of the Dukovany construction project and related to the provision of the fuel fabrication services required for both reactors for a specified period. The outlook for Westinghouse's compound annual growth rate for adjusted EBITDA remains 6% to 10% over the next five years, excluding the impact of the expected $170 million (US) increase in its 2025 adjusted EBITDA. Cameco owns a 49% interest in Westinghouse and its partner, Brookfield Renewable Partners, owns the remaining 51%. Caution about forward-looking informationThis news release includes statements and information about our expectations for the future, which we refer to as forward-looking information. Forward-looking information is based on our current views, which can change significantly, and actual results and events may be significantly different from what we currently expect. Examples of forward-looking information in this news release include our expectations regarding: Westinghouse's participation in the Dukovany power plant construction project; an increase in Westinghouse's adjusted EBITDA; Westinghouse taking this increase into consideration in determining the 2025 distribution payable to Cameco; the financial benefits for Westinghouse, as subcontractor, over the term of the Dukovany construction project and the expected future growth in Westinghouse's compound annual growth rate for adjusted EBITDA. Material risks that could lead to different results include the risk that Westinghouse is not able to participate in the Dukovany construction project on a basis that achieves the currently expected benefits to Westinghouse for any reason, or that Cameco may not derive the expected increases in its share of Westinghouse's adjusted EBITDA, or that Westinghouse does not achieve the expected future annual growth in adjusted EBITDA. In presenting the forward-looking information, we have made material assumptions which may prove incorrect about Westinghouse's participation in the Dukovany construction project and related potential benefits to Westinghouse, and continuing growth in Westinghouse's compound annual growth rate for adjusted EBITDA. Non-IFRS MeasuresAdjusted EBITDA is a measure that does not have a standardized meaning or a consistent basis of calculation under International Financial Reporting Standards (a non-IFRS measure). Westinghouse's adjusted EBITDA is defined as its net income, adjusted for the impact of certain expenses, costs, charges or benefits incurred in such period which are either not indicative of underlying business performance or that impact the ability to assess the operating performance of its business. For more information regarding our use of this non-IFRS measure see our most recent annual and quarterly Management's Discussion and Analysis. ProfileCameco is one of the largest global providers of the uranium fuel needed to power a secure energy future. Our competitive position is based on our controlling ownership of the world's largest high-grade reserves and low-cost operations, as well as significant investments across the nuclear fuel cycle, including ownership interests in Westinghouse Electric Company and Global Laser Enrichment. Utilities around the world rely on Cameco to provide global nuclear fuel solutions for the generation of safe, reliable, carbon-free nuclear power. Our shares trade on the Toronto and New York stock exchanges. Our head office is in Saskatoon, Saskatchewan, Canada. As used in this news release, the terms we, us, our, the Company and Cameco mean Cameco Corporation and its subsidiaries unless otherwise indicated. View source version on Contacts Investor inquiries Cory Kos 306-716-6782 cory_kos@ Media inquiries Veronica Baker 306-385-5541 veronica_baker@
